<?xml version="1.0" encoding="UTF-8"?>
<document id="29445180">
	<sentence id="s1" text="Here, we determine that non-canonical IKKα-RelB pathway activation of KRAS-mutant tumor cells mediates MPE development and this is fueled by host-provided interleukin IL-1β.">
		<entity id="s1.e1" charOffset="43-47"
			type="GENE" text="RelB" ontology_id="5971"/>
		<entity id="s1.e2" charOffset="70-74"
			type="GENE" text="KRAS" ontology_id="3845"/>
		<entity id="s1.e3" charOffset="82-87"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e3"
		    e2="s1.e3" pgr="true"/>
		<pair id="s1.p2" e1="s1.e1"
		    e2="s1.e3" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Indeed, IKKα is required for the MPE-competence of KRAS-mutant tumor cells by activating non-canonical NF-κB signaling.">
		<entity id="s2.e1" charOffset="51-55"
			type="GENE" text="KRAS" ontology_id="3845"/>
		<entity id="s2.e2" charOffset="63-68"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s2.e3" charOffset="103-105"
			type="GENE" text="NF" ontology_id="23114"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="true"/>
		<pair id="s2.p2" e1="s2.e2"
		    e2="s2.e3" pgr="false"/>
	</sentence>
	<sentence id="s3" text="Importantly, IL-1β-mediated NF-κB induction in KRAS-mutant tumor cells, as well as their resulting MPE-competence, can only be blocked by co-inhibition of both KRAS and IKKα, a strategy that overcomes drug resistance to individual treatments.">
		<entity id="s3.e1" charOffset="28-30"
			type="GENE" text="NF" ontology_id="23114"/>
		<entity id="s3.e2" charOffset="47-51"
			type="GENE" text="KRAS" ontology_id="3845"/>
		<entity id="s3.e3" charOffset="59-64"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s3.p1" e1="s3.e3"
		    e2="s3.e3" pgr="true"/>
		<pair id="s3.p2" e1="s3.e1"
		    e2="s3.e3" pgr="false"/>
	</sentence>
	<sentence id="s4" text="Hence we show that mutant KRAS facilitates IKKα-mediated responsiveness of tumor cells to host IL-1β, thereby establishing a host-to-tumor signaling circuit that culminates in inflammatory MPE development and drug resistance">
		<entity id="s4.e1" charOffset="26-30"
			type="GENE" text="KRAS" ontology_id="3845"/>
		<entity id="s4.e2" charOffset="75-80"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e2" pgr="true"/>
	</sentence>
</document>
